Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Is that drug ad for me? People pay more attention to pharma DTC for familiar conditions, study finds
4 years ago
Pharma
Marketing
Only a pawn in their game: Orphan drug tax credit on the chopping block again under Dem spending bill
4 years ago
FDA+
Scoop: Eli Lilly and AC Immune quietly scrapped Alzheimer’s studies for the centerpiece of $2B deal months ago
4 years ago
Deals
R&D
Alnylam’s John Maraganore isn’t the only CEO to leave his post; CRISPR’s chief commercial officer takes the ...
4 years ago
Peer Review
'I want to be a granddad': Why John Maraganore left and where he (and Alnylam) are going
4 years ago
People
A month after Biocon was handed a Form 483, documents reveal lackluster conditions
4 years ago
Manufacturing
Riding Covid-19 high, Aspen plans new additions at South African production site
4 years ago
Manufacturing
Gene therapy startup Jaguar set to join NC manufacturing boom with $125M facility
4 years ago
Manufacturing
Despite FDA go-ahead, Emergent still sits on millions of J&J vaccine doses — report
4 years ago
Coronavirus
Manufacturing
Catalent widens its ambitious expansion at Baltimore airport site, adding more viral vector suites
4 years ago
Manufacturing
Covid-19 manufacturing roundup: Biden pumps $500M into domestic testing production; Valneva mulls production deal
4 years ago
Coronavirus
Manufacturing
Ahead of closing $11.5B Acceleron buyout, Merck is on the hunt for more deals
4 years ago
R&D
Small biotech whiffs badly in PhIII pancreatic cancer study, prompting halt of another late-stage trial
4 years ago
R&D
Looking to win back investor confidence, BioMarin preps for its ‘largest launch’
4 years ago
Pharma
Marketing
White House kills off major drug pricing reforms as Democrats fail to coalesce around Medicare negotiation plan
4 years ago
Pharma
In a surprise departure, Alnylam's founding CEO John Maraganore is leaving the company — shares crater
4 years ago
People
A pair of partners at Frazier is following early-stage biotechs to the public market with an $830M fund. And they're ...
4 years ago
Financing
Checkmate CEO hits the exit as Art Krieg's crew struggles to warm investors to TLR9 strategy
4 years ago
People
Covid-19 roundup: US buys 50M Pfizer pediatric doses; Vir and GSK publish mAb data in NEJM
4 years ago
Coronavirus
Novartis in hot water again over alleged kickbacks, revealing new DoJ probe related to Entresto
4 years ago
Pharma
Cheap SSRI drug proves successful in reducing Covid-related hospitalization times in large trial
4 years ago
R&D
Coronavirus
Novavax takes protein-based Covid-19 vaccine overseas, asking for an approval in the UK
4 years ago
Coronavirus
Koch leads mammoth $215M infusion into AI startup boasting 'largest database' of immune cells
4 years ago
Financing
AI
Pfizer, Novartis, Janssen and other biotechs sign onto NIH/FDA program to develop new gene therapies for rare ...
4 years ago
Cell/Gene Tx
FDA+
First page
Previous page
621
622
623
624
625
626
627
Next page
Last page